BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6997895)

  • 1. Salutary effects of prostacyclin in endotoxic shock.
    Lefer AM; Tabas J; Smith EF
    Pharmacology; 1980; 21(3):206-12. PubMed ID: 6997895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial actions of prostacyclin in traumatic shock.
    Lefer AM; Sollott SL; Galvin MJ
    Prostaglandins; 1979 May; 17(5):761-7. PubMed ID: 386429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Eur J Pharmacol; 1984 Jan; 97(1-2):37-46. PubMed ID: 6698110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J; Hock CE; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of arachidonic acid during hemorrhagic shock in the dog.
    Flynn JT; Lefer AM
    Circ Res; 1977 Apr; 40(4):422-8. PubMed ID: 844155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid in splanchnic artery occlusion shock.
    Bridenbaugh GA; Flynn JT; Lefer AM
    Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer DJ; Lefer AM
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):293-9. PubMed ID: 2464101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial actions of imidazole in endotoxin shock.
    Smith EF; Tabas JH; Lefer AM
    Prostaglandins Med; 1980 Apr; 4(4):215-25. PubMed ID: 6994157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H; Yanagisawa A; Lefer AM
    Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA; Lefer AM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H; Stahl GL; Lefer AM
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of an infusion of prostacyclin on their endotoxin shock in rabbits.
    Matthias FR; Ditter H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):209-18. PubMed ID: 1695178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N; Siegfried M; Tsao P; Lento P; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock.
    Fletcher JR; Ramwell PW; Harris RH
    Adv Shock Res; 1981; 5():143-8. PubMed ID: 7030016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock.
    Lefer AM
    Klin Wochenschr; 1982 Jul; 60(14):713-6. PubMed ID: 6181287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock.
    Hock CE; Lefer AM
    Peptides; 1985; 6(3):547-53. PubMed ID: 3934648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock.
    Bottoms GD; Templeton CB; Fessler JF; Johnson MA; Roesel OF; Ewert KM; Adams SB
    Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.